<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483297</url>
  </required_header>
  <id_info>
    <org_study_id>AK1320-101</org_study_id>
    <nct_id>NCT04483297</nct_id>
  </id_info>
  <brief_title>First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS)</brief_title>
  <official_title>First-In-Human Study of AK1320 Encapsulated Microspheres (AK1320 MS) In Subjects With Degenerative Spondylolisthesis and Concomitant Symptomatic Spinal Stenosis Who Are Undergoing Decompression And Single Level Instrumented Posterolateral Lumbar Autograft Fusion Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asahi Kasei Pharma Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Emergent Clinical Consulting</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Asahi Kasei Pharma Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The safety and efficacy of AK1320 MS will be evaluated in patients with degenerative
      spondylolisthesis and concomitant symptomatic spinal stenosis who are undergoing
      decompression and single level instrumented posterolateral lumber autograft fusion surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This will be a first in human Phase I, ascending dose, multi-center, randomized patient study
      evaluating the efficacy, safety, PK of AK1320 MS. The study will enroll up to 4 dose
      escalating cohorts with each cohort having 2 treatment groups, the AK1320 MS group (n=7) and
      the Control group (n=3).
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">August 2020</start_date>
  <completion_date type="Anticipated">April 2023</completion_date>
  <primary_completion_date type="Anticipated">April 2023</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Summary of Neurological Status</measure>
    <time_frame>24 months</time_frame>
    <description>Neurological status will be determined preoperatively and postoperatively using a comprehensive neurological status scale. Neurological status is based on four types of measurements: lower extremity motor, dermatomal sensation, reflexes and straight leg raise.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Successful Fusion</measure>
    <time_frame>24 months</time_frame>
    <description>Fusion will be evaluated through CT scans. Successful fusion will be defined as complete bridging bone between the index level transverse processes with a lack of lucency or lucent lines through the fusion mass.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oswestry Low Back Pain Disability Questionnaire (ODI)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>36-Item Short Form Survey (SF-36v2Â®)</measure>
    <time_frame>24 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>AK1320 plasma concentrations</measure>
    <time_frame>Pre-op(day 0), Post-op (day 0, day1), 1 week, 2 weeks, 3 weeks, 4 weeks, 5 weeks and 6 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Degenerative Spondylolisthesis</condition>
  <condition>Spinal Stenosis</condition>
  <arm_group>
    <arm_group_label>AK1320 MS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AK1320 MS + Local Autologous Bone + Posterior Fixation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Local Autologous Bone + Posterior Fixation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>AK1320 MS</intervention_name>
    <description>AK1320 MS + Local Autologous Bone + Posterior Fixation. Ascending Dose.</description>
    <arm_group_label>AK1320 MS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Local Autologous Bone + Posterior Fixation</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Involved level L1 to S1

          2. Use of local autologous bone only.

          3. Degenerative spondylolisthesis up to Meyerding's Classification Grade 1 or 2.

          4. Moderate or higher disability as assessed by Oswestry Disability Index.

          5. Neurogenic claudication and/or radiculopathy with or without back pain.

          6. Male or female over 22 years of age and less than 81 years of age.

        Exclusion Criteria:

          1. Prior lumbar decompression or spine fusion attempt (any level).

          2. Undergoing concurrent interbody fusion.

          3. Requires spinal fusion at more than one lumbar level.

          4. Degenerative scoliosis.

          5. BMI &gt; 35.

          6. Radiographically confirmed significant spinal instability.

          7. Active or recent (within the past two (2) years) worker's compensation litigation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>22 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>AK1320-101 Project Manager</last_name>
    <phone>610-454-7200</phone>
    <email>AK1320-101@emergentclinical.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>London Health Sciences Centre</name>
      <address>
        <city>London</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sunnybrook Health Sciences Centre</name>
      <address>
        <city>Toronto</city>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 14, 2020</study_first_submitted>
  <study_first_submitted_qc>July 22, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 22, 2020</last_update_submitted>
  <last_update_submitted_qc>July 22, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>degenerative spondylolisthesis</keyword>
  <keyword>spinal stenosis</keyword>
  <keyword>posterolateral lumber fusion surgery</keyword>
  <keyword>autograft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Stenosis</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Constriction, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

